Booster doses of an inactivated F genotype mumps vaccine enhance immunogenicity in mice
The mumps virus (MuV) causes a highly contagious human disease characterized by swelling of the parotid glands. Although the administration of an attenuated Jeryl Lynn (JL) MuV vaccine shows efficacy in reducing the incidence of MuV infection, sporadic mumps outbreaks still occur in vaccinated popul...
Main Authors: | Seo Yeon Kim, Tae-Young Lee, Yun-Ho Hwang, Dokeun Kim, You-Jin Kim, Hyeran Won |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Vaccine: X |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S259013622400010X |
Similar Items
-
Improved Immunogenicity of the Inactivated F Genotype Mumps Vaccine against Diverse Circulating Mumps Viruses in Mice
by: Hyeran Won, et al.
Published: (2023-01-01) -
Immune response to the mumps component of the MMR vaccine in the routine of immunisation services in the Brazilian National Immunisation Program
by: Eliane Matos dos Santos, et al.
Published: (2014-06-01) -
Immunogenicity and safety of concomitant administration of the sabin-strain-based inactivated poliovirus vaccine, the diphtheria-tetanus-acellular pertussis vaccine, and measles-mumps-rubella vaccine to healthy infants aged 18 months in China
by: Yan Xu, et al.
Published: (2023-12-01) -
Safety and immunogenicity of heterologous recombinant protein subunit vaccine (ZF2001) booster against COVID-19 at 3–9-month intervals following two-dose inactivated vaccine (CoronaVac)
by: Yuting Liao, et al.
Published: (2022-11-01) -
The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine
by: Surakameth Mahasirimongkol, et al.
Published: (2022-03-01)